Systemic drug therapy for skin diseases can expose patients to potent drugs that can have serious or life threatening adverse effects. Written for dermatologists, primary care physicians, pharmacists and specialist nurses, this completely revised and updated second edition of a bestseller provides an accessible and concise aid to prescribing and monitoring systemic dermatologic therapy. Evidence based data or established guidelines have been included where possible. Common and important adverse drug effects and their management are covered along with some of the recent advances in drug treatment and monitoring of patients.
Acitretin. Acne Antibiotics. Alitretinoin. Androgens. Antiandrogens. Antibiotics Commonly Used for Skin Infections. Antifungals. Antihistamines. Antimalarials. Antivirals for HerpesViruses. Azathioprine. Azole antihelminths. Ciclosporin. Clofazimine. Colchicine. Corticosteroids. Cyclophosphamide. Dapsone. Fumaric Acid Esters. Hydroxycarbamide. Interferons. Intravenous Immunoglobulin. Isotretinoin. Ivermectin. Methotrexate. Mycophenolate Mofetil. Potassium Iodide. Propranolol. Appendices.
Sarah H. Wakelin, BSc, MB, BS, FRCP, Consultant Dermatologist, St Mary’s Hospital, Imperial College Healthcare Trust, London, UK, & Honorary Senior Lecturer, Imperial College, London, UK
Howard I. Maibach, MD, Department of Dermatology, University of California at San Francisco, USA
Clive B. Archer, BSc, MB, BS, MSc Med Ed, MD, PhD (Lond), FRCP (Edin, Glasg, Lond), Consultant Dermatologist, St John’s Institute of Dermatology, Guy’s and St Thomas’ Hospitals, London, UK, & Visiting Senior Lecturer in Pharmacology, Institute of Pharmaceutical Science, King’s College London, UK